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Mutational events as well as the selection of the optimal variant are essential steps in the evolution of living organisms.
The same principle is used in laboratory to extend the natural biodiversity to obtain better catalysts for applications in
biomanufacturing or for improved biopharmaceuticals. Furthermore, single mutation in genes of drug-metabolizing
enzymes can also result in dramatic changes in pharmacokinetics. These changes are a major cause of patient-specific
drug responses and are, therefore, the molecular basis for personalized medicine. MuteinDB systematically links
laboratory-generated enzyme variants (muteins) and natural isoforms with their biochemical properties including kinetic
data of catalyzed reactions. Detailed information about kinetic characteristics of muteins is available in a systematic way
and searchable for known mutations and catalyzed reactions as well as their substrates and known products. MuteinDB is
broadly applicable to any known protein and their variants and makes mutagenesis and biochemical data searchable and
comparable in a simple and easy-to-use manner. For the import of new mutein data, a simple, standardized, spreadsheet-
based data format has been defined. To demonstrate the broad applicability of the MuteinDB, first data sets have been
incorporated for selected cytochrome P450 enzymes as well as for nitrilases and peroxidases.
Database URL: http://www.MuteinDB.org
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Introduction
One of nature’s fundamental mechanisms to create genetic
diversity in living organisms is the creation of mutants,
which, in turn, leads to evolution. Mutational events and
selection of the optimal variant are essential to obtain a
better catalyst. In human medicine, enzyme polymorphisms
arising from evolutionary events have been identified since
the 1960s (1). Physicians recognized that patients with the
same disease responded differently to drugs, according to
which allelic variant their genomes were carrying. This
opened the road to what is nowadays called ‘personalized
medicine’ (2). Additionally, industry desires to artificially
improve enzymes through mutation and selection. To this
end, efficient protein engineering tools to create tailor-
made enzyme variants, named ‘muteins’, have been de-
veloped over the past decades (3). Muteins generated
either by rational design or by directed or designed evolu-
tion were adapted to the needs of industrial processes or
for completely new applications.
Increasing interest in personalized medicine and in
tailor-made enzymes in the fast-growing biocatalysis indus-
try has led to an exponential increase of literature about
muteins and their influence on enzymes’ kinetic properties.
.............................................................................................................................................................................................................................................................................................
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creative-
commons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided
the original work is properly cited. Page 1 of 9
(page number not for citation purposes)
Database, Vol. 2012, Article ID bas028, doi:10.1093/database/bas028
.............................................................................................................................................................................................................................................................................................
 at Forschungszentrum
 Juelich, Zentralbibliothek on A
ugust 6, 2013
http://database.oxfordjournals.org/
D
ow
nloaded from
 
In a plethora of examples, the artificial substitution of one
or more amino acids in a polypeptide resulted in a signifi-
cant increase or decrease of stability, turnover rate or sub-
strate specificity for the enzyme (4). Even new reactions or
activities on molecules that were not substrates for the nat-
ural parental enzyme can be caused by just a few or every
single mutation. For example, esterases could be changed
to hydroxynitrile lyases and epoxide hydrolases (5,6).
Papain, a protease, was modified to an enzyme with
efficient nitrile hydratase activity (7). Furthermore, the
fatty acid hydroxylase CYP102A1 and the camphor hydro-
xylase CYP101 were redesigned to efficient alkane hydro-
xylases (8–10). By a single mutation, the broadly applied
lipase CALB was modified to perform aldol additions and
epoxidations (11). More recently, a transaminase showing
almost no activity for a commercially interesting substrate
was mutated to a highly active and selective catalyst
enabling a new efficient industrial process for sitagliptin
production (12).
Information about specific proteins and their muteins
are widely spread in the literature. Many studies only
describe single mutation and its effects without comparison
to already known muteins. Possible additive effects of
single amino acid changes are scarcely described or used.
Even after a thorough and time-consuming literature
search, researchers face the problem of assembling and
presenting the data in an easy understandable and
comprehensive way. Essential information may be lost
such as details about potentially cooperative mutations or
reactions one would not expect in certain protein families.
Therefore, a web-accessible database combining available
knowledge about a specific enzyme and its muteins in
a single place are highly desirable. Such a database would
allow researchers to access relevant information about
their protein of interest in a fast and easy way and acceler-
ate the engineering of new and improved variants.
Existing, comprehensive enzyme engineering databases
such as CYPED are mainly focused on enzyme sequences
and their structures (13). Only a few databases go beyond
that and contain, to some extent, information about
muteins and their properties. The most recently published
database introducing mutein information is SuperCYP (14),
which exclusively addresses human cytochrome P450s.
Another example is SPROUTS (15), which provides details
on the influence of point mutations on protein stability.
The Protherm database (16) contains experimental thermo-
dynamic data, and BRENDA (17), a well-known enzyme
databases, includes only a small section about muteins.
Finally, the Protein Mutant Database (18) includes refer-
ences to mutant proteins from the literature. However,
none of these databases provides kinetic characteristics of
muteins and allows a fast, systematic and user-friendly way
to search for known mutations and catalyzed reactions of
interest. All these databases focus on enzymes and provide
information about their variants from the view of the pro-
tein. Additionally, none of the existing databases is search-
able by substrate or product molecule structures allowing
comparison of muteins with respect to their catalytic
properties.
In this article, we present the novel database MuteinDB
(http://www.MuteinDB.org). It is a user-friendly graphically
appealing database devoted to provide easy access to de-
tailed information on naturally occurring and laboratory-
evolved muteins as well as on the influence of mutations
on kinetics of catalyzed reactions, including inhibition. It
allows to search for the best biocatalyst for a given sub-
strate, reaction or product simply by substrate name,
Chemical Abstracts Service (CAS) number or molecule struc-
ture. In addition, a structure search tool offers the possibility
to predict muteins which most likely accept a new substrate,
if no enzyme/substrate properties were described so far.
MuteinDB overview
The MuteinDB is a platform to collect, catalog, and store
experimentally derived data about muteins from publicly
available sources as well as data directly submitted by the
scientists. Additionally, it allows flexible searches by reac-
tion type, molecular (sub) structures, substrate, product or
mutein name. MuteinDB provides details on catalyzed re-
actions, kinetic data (activity, kinetic resolution) and experi-
mental conditions used for data generation as well as for
possible substrates or products consumed or produced by a
reaction of choice including relevant scientific publication
or patent information. The schematic diagram in figure 1
illustrates the two major parts of MuteinDB. On the one
side the data import section, for standardized user-friendly
and automated data import to MuteinDB. And on the
other the data retrieval system which facilitates multiple
search options as well as data representation mechanisms.
Furthermore, it is possible to screen all enzyme variants
for known interactions with specific inhibitors. Substrate,
product and inhibitor data are linked to CAS and/or
CID number (PubChem) as a unique identifier for unam-
biguous reference. The use of these distinct identification
numbers allows even to extract information about (com-
parative) stereo- or enantioselectivity of individual muteins.
Furthermore, once the user has identified a mutein of inter-
est, information about its sequence, the employed expres-
sion hosts, cofactors, cosubstrates, and coproteins can be
directly shown. In the sequence view, all mutations of a
specific mutein are highlighted and liked to other muteins
with known mutations of the same position. Additionally,
the wild type sequence including all known amino acid ex-
changes which are again linked to muteins containing the
modified position is illustrated for all muteins.
For first-time users, a comprehensive frequently asked
question (FAQ) section and in-depth tutorial movies are
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provided. The key features are described in more detail
below.
Search options
In contrast to other databases, MuteinDB allows users not
only to query for muteins and mutations but also for sub-
strates, products, or inhibitors, using the corresponding
name or CAS number as well as catalyzed reaction types.
The database also provides means to easily and efficiently
search the data (e.g. by allowing to enter wildcards in the
values) and display it in a clear, tabular form.
Structural search
Another important difference to other existing databases is
the fully integrated (sub) structure search tool. It allows
searching for substances with a similar structure by drawing
an arbitrary chemical structure in the JME Molecule Editor
(19). The database will provide all possible hits related to
the drawn structure, and the user can navigate amongst
them to refine the search. Based on knowledge about
mutein/substrate combinations and their specific products,
this for the first time also allows predictions of other pos-
sible substrates and products for known muteins which
were not experimentally evaluated so far.
Individual features of MuteinDB
MuteinDB uses a mutein-based classification. A unique ID is
assigned to each mutein and is linked to the reference
source, the catalyzed reaction and the corresponding
wild type protein. This mutein-centric approach allows
more flexible and specific searches compared to the pub-
lication-based classification of the Protein Mutant Database
(18) or the reaction based classification of BRENDA (17).
Each reaction and publication reference can be independ-
ently surveyed, which is especially important when amino
acid changes result in new functionalities. An example for
such a case is the lipase CALB that was modified to a C–C
bond forming enzyme for aldol additions (11).
Basic information about underlying wild type protein
sequences, structures and source organism as well as com-
pound structures, their respective references and reactions
are retrieved from the public databases GenBank, PDB,
UniProt, PubChem, PubMed, CrossRef, and KEGG (20–24).
Wherever third party data is presented, it is linked to the
corresponding database entry.
Standardized format for data
collection and import
The recent introduction of experimental high-throughput
techniques required the development of standardized for-
mats for data from biological experiments. They facilitate
exchange of data, their storage in publicly accessible
repositories, increase experimental transparency and
allow reproduction of bioinformatic analyses from publica-
tions. For example, such formats are available for DNA-
microarray experiments (25), proteomics studies (26), and
data deriving from qPCR experiments (27). Most of them
are XML based, which can be difficult to create and ma-
nipulate. Therefore, simpler, spreadsheet-based formats
have been introduced which are more accessible for the
individual researcher. A prominent representative is the
MAGE-TAB format for DNA-microarray experiments (28).
Here, we propose a standardized spreadsheet-based data
exchange format for muteins and related experimental kin-
etic data. The MuteinDB import spreadsheet comprises
seven sections for each entry: (i) basic data; (ii) signal se-
quences; (iii) pH conditions; (iv) temperature conditions;
(v) storage stability; (vi) reaction data and (vii) activity
data. The basic data section includes the enzyme’s name,
the GenBank protein ID and the PDB ID (if available).
Additionally, the corresponding wild-type name and the se-
quence mutations are illustrated for muteins. The reaction
section contains the substrate and the product of the reac-
tion (both with CAS number and name), the enzyme classi-
fication (EC) number of the reaction and the reaction type.
The activity section can cover one of following types: conver-
sion activity, enatiomeric excess or inhibition. All three types
are followed by the corresponding kinetic values and the
experimental conditions. The provided standards for kinetic
data necessitate a minimum quality of biochemical protein
data (e.g enzyme activity provided in mmol product made by
mmol enzyme per minute).
A detailed description of the fields along with guidelines
for data collection and a template spreadsheet are avail-
able on the MuteinDB homepage. Standardized entry of
data into the spreadsheet is ensured by drop-down lists
for fields with a defined value set. Drop-down lists can be
extended if new values for a field are required.
For data import, the files are checked for data consist-
ency according to the guidelines and compared with the
already existing mutein data to prevent duplicate entries
(Figure 1). A detailed report on the import is provided,
allowing focused modification of the data to adjust it con-
forming to the guidelines. Upon successful import, the data
is reviewed by an expert team at Graz University of
Technology and feedback is provided to the submitter.
After all inconsistencies are resolved, the new content is
publicly released. New data can be submitted any time
and is made available immediately after the review.
MuteinDB structure and
implementation
The MuteinDB is implemented using Java, an object-
oriented and platform-independent programming
.............................................................................................................................................................................................................................................................................................
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language. The application is based on a 3-tier architecture
with an Oracle database as the persistence tier, an applica-
tion server (JBoss) as the middle tier and a WEB interface
as the client tier. Business logic is implemented using
Enterprise JavaBeans 3. The web interface depends on
JavaServer Faces 2, Asynchronous JavaScript and XML and
JBoss Seam. The relational database schema has been
designed to accommodate controlled vocabularies in form
of a data dictionary. Attributes with a defined value set are
linked to data dictionary entries to facilitate standardized
content in the database.
For substructure search (5), the JME Molecule Editor (19)
and the Chemistry Development Kid (CDK)—an open-
source Java library—are used.
Use of MuteinDB
The MuteinDB was developed as a user-friendly and
intuitive resource of mutein-related properties for scientists
in the fields of biology, biotechnology, organic chemistry
and pharmaceutical sciences. The top information bar
offers ‘FAQs’ where users will find helpful information.
Furthermore, first-time users will find tutorial movies ex-
plaining the database usage and the different MuteinDB
sections.
The simplest search option ‘Search by Substrate’ is dir-
ectly accessible via the home screen. The left side naviga-
tion bar gives access to further querying options.
Search options
(i) Substrate: enables the user to search for muteins
that convert a certain substrate of interest.
(ii) Reaction: enables the user to search for specific re-
actions by entering a molecule name or a CAS
number for the substrate and/or the product
(including single enantiomers)
(iii) Structure: enables the user to draw chemical struc-
tures to search for similar or exact (sub) structure
matches in either one or all of the molecule cate-
gories (substrate, product and/or inhibitor).
Figure 1. Schematic diagram of database structure. MuteinDB structure can be divided into two major parts. Firstly, the data
collection and import structure within MuteinDB, illustrated on the left. Detailed guidelines structure and specify the correct and
unified data collection as well as the data import. The standardized excel data import template guarantees data quality and
consistency. During the automated data import from the data import excel sheet, metadata from third party databases such as
PubMed, PubChem, GenBank and CrossRef are retrieved and added. The data import procedure ends either with a summary
including imported muteins, molecules, reactions, activities or with a detailed error report. Secondly, stored public mutein data
can be easily retrieved via various search mechanisms. For example, chemical structures can be used for identifying molecules of
interest and their catalyzed reactions. Results are presented in tabular listings with links to third party databases or to detailed
information contained in MuteinDB.
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(iv) Inhibitor: enables the user to search for inhibitors of
muteins and wild-type enzymes by entering a mol-
ecule name or a CAS number.
(v) Mutation: enables the user to search for muteins
containing mutations at a certain position.
(vi) Wild-type: enables the user to browse all muteins
and their reactions for a defined wild-type enzyme.
(vii) Mutein: enables the user to search for all relevant
reactions for a defined mutein name.
To keep the additional querying options simple and flex-
ible, further refinements of the query can, but do not have
to, be specified or selected. For example, the search can be
restricted amongst others to the reaction type, the under-
lying wild type protein, or to a specific organism.
All text fields are equipped with ‘suggest input’. While
typing a box will appear and provide suggestions one can
choose from. Furthermore, selected fields allow ‘wildcard
search’ with ‘*’ as a placeholder.
Example workflow
The ability to search for exact or similar structures is one of
the unique main features of the MuteinDB. Therefore, we
will describe this search type in more detail and use it as
example to demonstrate the ability of MuteinDB for valu-
able data retrieval (Figure 2).
Selecting ‘Search by Structure’ will open the JME
Molecule Editor Applet (19) and allows the user to draw
an arbitrary chemical structure (Figure 2A). After submit-
ting the search, results will be presented as a table listing
all molecules containing the drawn structure (Figure 2B).
The ‘structure result’ page proposes several related sub-
strates, products and inhibitors with similar structures to
the drawn molecule structure. In all result views, moving
the cursor over a molecule name will show its chemical
structure. Additionally, each molecule name is linked to
PubChem (22). This also facilitates the search if the CAS
number or the exact molecule name is unknown or if dif-
ferent trivial names of the molecule are commonly used.
One or several molecules can be selected via checkboxes
and can be used for a subsequent search by substrate/prod-
uct or inhibitor. The results are shown again in tabular form
listing all muteins that convert the selected substrates or
produce the selected products or are inhibited by the
chosen inhibitors.
Selecting ‘testosterone’ from the list for a subsequent
search reveals several muteins that are able to convert
this steroid (Figure 2C). This supports predictions about pos-
sible transformations of testosterone derivatives where
no experimental data is available so far. Hits from such
searches are preferred muteins for experimental evaluation.
Information about the catalyzed reactions such as sub-
strate, product and reaction type are presented in the ‘sub-
strate view’ (Figure 2D). A link to KEGG reaction (29) is
provided when a corresponding entry exists. As the kinetic
data are one of the most important pieces of information
stored in the database, kinetic parameters such as Km and
kcat are given. Furthermore, enantiomeric access and
E-values are provided if available. The view can be custo-
mized using ‘edit display settings’.
As multiple publications may have reported the same
reaction for a given mutein, the one stating the highest
activity is shown in the main result screen. By using the
expand button the data from the other reports are also
shown. Clicking on the mutein name will bring up the
‘mutein view’ where detailed information about the
mutein and the reaction are provided.
In the ‘substrate section’, several mouse-over buttons
(Figure 2D) give further information about the catalyzed
reaction. ‘C’ shows comments on the reaction, ‘W’ gives
activity data of the underlying wild-type reference, ‘R’
shows information about reaction conditions and analysis
and ‘L’ provides detailed information about the corres-
ponding literature. The PubMed ID or the digital object
identifier (DOI, http://crossref.org) of the publications are
given and directly linked to PubMed or to the webpage
associated with the digital object identifier, respectively.
Additionally, the EC number is provided and linked to the
comprehensive enzyme database BRENDA (Figure 2F–H).
The ‘sequence section’ shows the mutein sequence
aligned with its corresponding wild-type sequence
(Figure 2E). In the mutein sequence, the mutations are
highlighted in violet. The sequence can be downloaded as
FASTA format. The amino acids of the wild-type sequence
highlighted in blue mark the positions of known mutations.
These positions are linked to the ‘enzyme mutation view’.
In this view, all muteins that contain a mutation at this
position are listed. Via the mutein name it is possible to
navigate to the mutation view of the corresponding
mutein.
Another highlight of the MuteinDB is the ability to select
two or more muteins, which convert the substrate of inter-
est or form the product of interest, for comparison in side
by side view. In the ‘compare view’ the kinetic data of the
catalyzed reaction as well as information about the muta-
tions, expression system and involved cofactors and
coproteins are displayed.
Inhibitors have a special status and may have been
reported in the ‘structure result’ page for the inhibitor
search. The results are shown in tabular form (Figure 3)
listing muteins that are inhibited by the chemical com-
pound. Instead of kinetic data, the inhibitor constant Ki
or the IC50 value are provided. Additionally, the underlying
reaction used to determine the inhibitor constant is shown.
As the same inhibitor measurements can be found in
different publications, only the one with the highest inhib-
ition constant is shown as the main result. Via the expand
button, the data of the other literature sources is shown.
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Figure 2. MuteinDB structure search, its results and the capabilities of the MuteinDB webinterface. (A) The MuteinDB (sub)
structure search uses the JME editor, which allows users to draw arbitrary molecular structures. (B) The user-drawn structure is
used as seed for the following database search and shown on top of the structure search result table. In this table all molecules,
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The mutein name is again linked to the ‘mutein view’,
where detailed information on the mutein and the inhib-
ition reaction are provided.
Results and conclusions
MuteinDB is a comprehensive and carefully curated data-
base for specific muteins and their kinetic data of catalyzed
reactions including inhibition. It provides in-depth informa-
tion on mutein properties combined with flexible search
capabilities. The MuteinDB has been designed to be
broadly applicable to proteins and their muteins from any
enzyme class including those with no known catalytic func-
tion. We demonstrated this by entering data sets of several
enzymes and their variants of different enzyme classes.
Presently, the understanding of the structure–function
relationship of proteins is still limited. Scientists are trying
to tackle the problem from different perspectives (from
medicine and pharmacokinetics, to structural biology or
applied biocatalysis) and are, therefore, interested in how
mutations can influence catalytic properties.
By means of MuteinDB a user can find enzymes
that catalyze a particular reaction not only in expected
enzyme classes but also in others [e.g. a C–C bond forming
mutein derived from a hydrolase (30)]. This feature helps to
identify potential starting points for further enzyme engin-
eering. Moreover, medical scientists can get information
about the influence of mutations on the drug metabolism
and the in vivo activation. This helps to predict a patient’s
personal response to certain administereddrugs. In addition,
the implemented structure search for substrates, products
and inhibitors allows the prediction of structure scaffolds
that could be accepted by muteins. This might provide help-
ful information for the development of new biocatalysts
Figure 2. Continued
substrates, products or inhibitors which contain the query structure are presented. A selection of these molecules can be used for
a subsequent ‘Search by Reaction’. (C) All wild type enzymes and muteins which catalyze the selected molecules are shown.
(D) For each row of the tabular result, further information can be obtained via the mutein or wild type name. The detailed
information is organized in four main categories: (i) basic data; (ii) properties; (iii) substrate and (iv) sequence. (E) The ‘Sequence’
tab of the selected mutein allows to explore the sequence of the mutein as well as the wild type sequence. Known mutations are
highlighted and linked to the corresponding entries of MuteinDB. (F) Information in the ‘Substrate’ tab is linked to third party
databases. For example, (F) molecules are linked to PubChem, (H) EC-Numbers to Brenda and (G) literature to PubMed or to its
DOI location. For muteins, experimental settings and wild type activity values are available from the ‘Substrate’ tab.
Figure 3. Result display of the MuteinDB web-interface for testosterone as a substrate. Information within the result listing for
each mutein is by default grouped into catalyzed reaction and kinetic data. Reaction information comprises the reaction type as
well as the catalyzed substrate and product. Molecules are directly linked to their corresponding PubChem entry. Additionally,
the molecule structure can be displayed by moving over the compound’s name. Important kinetic parameters such as K value,
activity value including its unit as well as the relative activity in (%) are directly available in the result view. All presented
information and further links for each mutein or wild type is directly linked by its name.
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and, most probably, will facilitate drug metabolite predic-
tion in pharmaceutical research and development.
At present MuteinDB contains several thousand
reactions (Table 1) for muteins of different enzyme
classes. It is the largest collection of kinetic data of
muteins compiled in a single database. To demonstrate
the general applicability of the database, different types
of enzymes from different origins have been searched
in literature and imported into MuteinDB. Data were
collected by searching SciFinder (www.cas.org) and
PubMed (21) abstracts for specific keywords. Detailed
data from texts, tables and figures were manually ex-
tracted from the matching full-text publications and
were curated by a team of scientists, who enriched the
published information with first-hand kinetic data wher-
ever possible.
CYP2D6 and CYP3A4 are human liver enzymes and
known to be involved in drug metabolism. Both enzymes
have been chosen as primary data sets due to their pro-
nounced polymorphism and high importance for human
drug and xenobiotic metabolism. We selected CYP102A1
(BM-3) from Bacillus megaterium as a prokaryotic represen-
tative. This protein is one of the most mutated and inves-
tigated proteins known.
To import the data, we used the standardized spread-
sheet-based import file format described previously. It con-
tains all attributes necessary to describe a mutein and its
properties.
In order to augment the database content, data col-
lection is on-going. To make the database as compre-
hensive and up-to-date as possible, we are addressing
the research community with a request to aid us in
the collection of kinetic data sets for enzymes of differ-
ent type and origin. We appreciate any contribution to
the database both updates to existing data and new
kinetic data sets.
Future directions
In the course of integrating new data sets, the MuteinDB
will be adapted, and the guidelines for data collectionwill be
adjusted. Feedback from end users and data collectors will
ensure a continued focus on a user-friendly development.
The collection of data sets was carried out as part of the
OXYGREEN (www.oxygreen.org) project, a research collab-
oration funded by the European Commission Seventh
Framework Programme (EU FP7), and will be continued to
do so. MuteinDB will be used and extended in the context
of BIONEXGEN, a recently funded EU project. To ensure
continuation of data collection and curation of the data-
base, MuteinDB will be integrated into future projects.
A downloadable version of the MuteinDB is in prepar-
ation. It will be provided for companies or universities that
would like to store their own data in-house. The data can
be integrated into the public online database on request.
The download will be available in exchange for newmutein
data sets or for a fee for database curation and data
collection.
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